As President and CEO of Organogenesis Inc., Gary S. Gillheeney, Sr. has led the company’s growth and development for more than 15 years. When Mr. Gillheeney joined the company as CFO/COO, Organogenesis had just launched its flagship product, Apligraf® in wound care. Under his guidance, the company has grown, both through organic development as well as acquisitions, into its current position as a leading regenerative medicine company offering a portfolio of products for the advanced wound care and surgical biologics markets. For his work at Organogenesis, Mr. Gillheeney was recognized in 2009 as one of Ernst & Young’s “Entrepreneur of the Year.”
Mr. Gillheeney’s career in Executive Management, Operations and Finance spans more than 25 years. Prior to joining Organogenesis, he held executive positions at Innovative Clinical Solutions, Ltd. as Chief Operating Officer, Chief Financial Officer, as well as Treasurer and Secretary. Prior to that he held positions as Senior Vice President, Chief Financial Officer, Treasurer, and Assistant Secretary at Providence Energy Corporation. Mr. Gillheeney has a B.S. in Accounting from American International College and an MBA from Bryant College.